Unconfirmed Assumes qualification, daily effective compounding and unchanged rates; before fees and taxes. Actual bank crediting can differ.
Promotions and qualifying rates
Limited-time offerUp to 5.10% APY · Utah Rebrand Boost through January 31, 2027 · up to 4 months. Enroll before 2027-01-31; confirm the bank’s cutoff.
The advertised top rate requires $0. Promotion balance cap: $500,000. Utah residential-address customers only: +1.00% Rebrand Boost on the portion up to and including $500,000, through January 31, 2027; open by that date. The benefit ends on that fixed date, not four full months after opening. Nonqualifying customers receive the 4.10% advertised variable base APY. Complete tier math is Unconfirmed.
Rates can change. Confirm the current terms with the bank before opening an account. Last verified dates show when the approved rates were captured. Estimates require verification within the last 24 hours.
Unconfirmed: Eligibility, Maximum balance, Nationwide, Other service fees, Tiers. The bank information reviewed did not establish these terms.
Minimum opening deposit
$100
Minimum balance to earn interest
$0
Eligibility
Consumer accounts. Utah Rebrand Boost requires a qualifying Utah residential street address at opening; PO boxes, forwarding and registered-agent addresses do not qualify. One boosted account per taxpayer ID. Non-Utah customers receive the advertised variable base rate; additional applicant requirements are Unconfirmed.
Key conditions
Advertised variable base APY is 4.10%. The bank also describes amounts above the boost cap as a 4.10% interest rate, so the full marginal APY schedule is Unconfirmed. Initial online funding up to $2,500 is a channel limit. Six covered remote withdrawals per statement cycle, then $5 each; in-person/ATM withdrawals excluded.
Accordia’s official product page rejected this research fetch. Use our dated account reference for independently checked information and the bank’s disclosures before applying. Missing information does not establish a fee-free account, unrestricted transfers or nationwide availability. A fuller assessment depends on resolving the source-access gap.
By High Yield
Published
Reviewed
Current source access limits this baseline
Accordia’s official product page rejected this research fetch. Use our dated account reference for independently checked information and the bank’s disclosures before applying. Missing information does not establish a fee-free account, unrestricted transfers or nationwide availability. A fuller assessment depends on resolving the source-access gap.
Baseline assessment and current terms
Evaluate this account at the balance you intend to keep and the withdrawal frequency you need. The current rates-and-terms reference distinguishes checked information from unresolved conditions. A larger advertised APY is not sufficient if qualification, fees or access make the account a poor fit.
This source-based baseline has not included a hands-on account test or established a representative customer-service rating. Publication of the review does not approve missing financial data. Rates are variable; follow the dated reference and official disclosures before opening.
Recorded rates describe what our sources showed, rather than a prediction. Reviewed reader experiences will be added when supported public evidence is available.
Observed rates
Last 90 days · Aug 16, 2026–Nov 14, 2026 · at $10,000.
No usable checked rate history at this balance in the last 90 days.
These are historical observations. The current review status, official sources and latest terms appear in the account reference. Promotions and qualifying APYs are excluded from this ongoing-rate history.
Quill Bank is the legal institution behind this account (FDIC certificate 33823). Different brands or branches at the same institution do not create separate insurance limits. Coverage depends on ownership category and the insurer’s rules.
No other active accounts at this institution are currently listed in our curated catalog. This is not a complete inventory of its brands.
Comments
View full discussion →